12.18.24 Study shows link between semaglutide use and NAION A December study showed that a once-weekly semaglutide doubles the five-year risk of developing non-arteritic anterior ischemic optic neuropathy (NAION)
Some patients may experience gastrointestinal side effects such as nausea, particularly when consuming large meals or foods high in fat, which can further influence food choices and eating patterns during treatment
Glucagon-like peptide-1 GLP-1 is an incretin hormone produced by the EECs in response to ingested nutrients to stimulate glucose-dependent insulin secretion and suppress appetite
Change Your Life Today For Only $249/month Conclusion Semaglutide offers a powerful solution for managing sugar cravings, addressing both the physiological and psychological drivers of sugar consumption
Endocrine Society Annual Meeting, 2025
In the pancreas, this binding stimulates glucose-dependent insulin secretion from beta cells while suppressing inappropriate glucagon release from alpha cells